Dementia Archives - Insights Get the latest news and education from Mayo Clinic Laboratories Wed, 15 Apr 2026 15:09:48 +0000 en-US hourly 1 https://wordpress.org/?v=7.1.3 Alzheimer’s Disease Blood Biomarkers https://news.mayocliniclabs.com/2026/02/09/alzheimers-disease-blood-biomarkers/ https://news.mayocliniclabs.com/2026/02/09/alzheimers-disease-blood-biomarkers/#respond Mon, 09 Feb 2026 12:00:00 +0000 https://news.mayocliniclabs.com/?p=120420 Alzheimer’s Disease Blood BiomarkersThis presentation offers a clear introduction to emerging blood based biomarkers for Alzheimer’s disease.

The post Alzheimer’s Disease Blood Biomarkers appeared first on Insights.

]]> https://news.mayocliniclabs.com/2026/02/09/alzheimers-disease-blood-biomarkers/feed/ 0 Rational Approaches to Testing in the MCI/Dementia Setting https://news.mayocliniclabs.com/2025/12/31/rational-approaches-to-testing-in-the-mci-dementia-setting/ https://news.mayocliniclabs.com/2025/12/31/rational-approaches-to-testing-in-the-mci-dementia-setting/#respond Wed, 31 Dec 2025 12:00:00 +0000 https://news.mayocliniclabs.com/?p=119758 Rational Approaches to Testing in the MCI/Dementia SettingIn this video, Dr. Vijay Ramanan shares perspectives on rational approaches to testing in the cognitive neurology, mild cognitive impairment, and dementia settings.

The post Rational Approaches to Testing in the MCI/Dementia Setting appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/12/31/rational-approaches-to-testing-in-the-mci-dementia-setting/feed/ 0 Advancing precision diagnostics for neurodegenerative disorders https://news.mayocliniclabs.com/2025/11/25/advancing-precision-diagnostics-for-neurodegenerative-disorders/ https://news.mayocliniclabs.com/2025/11/25/advancing-precision-diagnostics-for-neurodegenerative-disorders/#respond Tue, 25 Nov 2025 14:00:00 +0000 https://news.mayocliniclabs.com/?p=118903 Advancing precision diagnostics for neurodegenerative disordersSAAmplify™-αSYN testing offers unprecedented accuracy in diagnosing Parkinson’s and Lewy body dementia.

The post Advancing precision diagnostics for neurodegenerative disorders appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/11/25/advancing-precision-diagnostics-for-neurodegenerative-disorders/feed/ 0 Join us on Oct. 29 for a SAAmplify-αSYN testing webinar https://news.mayocliniclabs.com/2025/09/08/join-us-on-oct-29-for-a-saamplify-%ce%b1syn-testing-webinar/ https://news.mayocliniclabs.com/2025/09/08/join-us-on-oct-29-for-a-saamplify-%ce%b1syn-testing-webinar/#respond Mon, 08 Sep 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=118036 Join us on Oct. 29 for a SAAmplify-αSYN testing webinarJoin us for a webinar exploring the revolutionary way SAAmplify™–αSYN testing, which is offered by Mayo Clinic Laboratories in collaboration with Amprion, is improving diagnostic accuracy for patients with neurodegenerative disorders.

The post Join us on Oct. 29 for a SAAmplify-αSYN testing webinar appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/09/08/join-us-on-oct-29-for-a-saamplify-%ce%b1syn-testing-webinar/feed/ 0 Alzheimer’s Disease: Understanding CSF Biomarkers https://news.mayocliniclabs.com/2025/09/03/alzheimers-disease-understanding-csf-biomarkers/ https://news.mayocliniclabs.com/2025/09/03/alzheimers-disease-understanding-csf-biomarkers/#respond Wed, 03 Sep 2025 10:00:00 +0000 https://news.mayocliniclabs.com/?p=118039 Alzheimer’s Disease: Understanding CSF BiomarkersDiagnostic advances allow earlier & more accurate detection of Alzheimer's using cerebrospinal fluid biomarkers.

The post Alzheimer’s Disease: Understanding CSF Biomarkers appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/09/03/alzheimers-disease-understanding-csf-biomarkers/feed/ 0 The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D. https://news.mayocliniclabs.com/2025/08/14/the-promise-challenges-and-global-impact-of-ai-tools-bill-morice-m-d-ph-d/ https://news.mayocliniclabs.com/2025/08/14/the-promise-challenges-and-global-impact-of-ai-tools-bill-morice-m-d-ph-d/#respond Thu, 14 Aug 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=117845 The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

The post The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/08/14/the-promise-challenges-and-global-impact-of-ai-tools-bill-morice-m-d-ph-d/feed/ 0 Neurodegenerative Diseases: Diagnostic Advancements https://news.mayocliniclabs.com/2025/07/01/neurodegenerative-diseases-diagnostic-advancements/ https://news.mayocliniclabs.com/2025/07/01/neurodegenerative-diseases-diagnostic-advancements/#respond Tue, 01 Jul 2025 10:00:00 +0000 https://news.mayocliniclabs.com/?p=117204 Neurodegenerative Diseases: Diagnostic AdvancementsFor healthcare professionals seeking to enhance their understanding of the assessment and treatment options for patients with neurodegenerative diseases.

The post Neurodegenerative Diseases: Diagnostic Advancements appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/07/01/neurodegenerative-diseases-diagnostic-advancements/feed/ 0 Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D. https://news.mayocliniclabs.com/2025/04/24/revolutionary-technology-advances-diagnosis-of-neurodegenerative-disorders-bill-morice-m-d-ph-d/ https://news.mayocliniclabs.com/2025/04/24/revolutionary-technology-advances-diagnosis-of-neurodegenerative-disorders-bill-morice-m-d-ph-d/#respond Thu, 24 Apr 2025 13:00:00 +0000 https://news.mayocliniclabs.com/?p=116101 Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by Russ Lebovitz, M.D., Ph.D., CEO and co-founder of Amprion. They discuss their strategic collaboration and the innovative SAAmplify™–αSYN (CSF) test.

The post Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/04/24/revolutionary-technology-advances-diagnosis-of-neurodegenerative-disorders-bill-morice-m-d-ph-d/feed/ 0 Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnostics https://news.mayocliniclabs.com/2025/03/26/mayo-clinic-laboratories-and-amprion-announce-collaboration-to-advance-neurodegenerative-disease-diagnostics/ https://news.mayocliniclabs.com/2025/03/26/mayo-clinic-laboratories-and-amprion-announce-collaboration-to-advance-neurodegenerative-disease-diagnostics/#respond Wed, 26 Mar 2025 14:00:00 +0000 https://news.mayocliniclabs.com/?p=115573 Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnosticsMayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the United States. The test (test ID ASYNC) is available today for clients of Mayo Clinic Laboratories through the collaboration that combines the expertise of both organizations to enhance patient care and improve diagnostic accuracy for neurodegenerative diseases.

The post Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnostics appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/03/26/mayo-clinic-laboratories-and-amprion-announce-collaboration-to-advance-neurodegenerative-disease-diagnostics/feed/ 0 New test distinguishes between prion disease and other causes of rapidly progressive dementia https://news.mayocliniclabs.com/2025/02/03/new-test-distinguishes-between-prion-disease-and-other-causes-of-rapidly-progressive-dementia/ https://news.mayocliniclabs.com/2025/02/03/new-test-distinguishes-between-prion-disease-and-other-causes-of-rapidly-progressive-dementia/#respond Mon, 03 Feb 2025 14:00:00 +0000 https://news.mayocliniclabs.com/?p=114501 New test distinguishes between prion disease and other causes of rapidly progressive dementiaPerformed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.

The post New test distinguishes between prion disease and other causes of rapidly progressive dementia appeared first on Insights.

]]> https://news.mayocliniclabs.com/2025/02/03/new-test-distinguishes-between-prion-disease-and-other-causes-of-rapidly-progressive-dementia/feed/ 0